{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T11:05:32Z","timestamp":1772622332470,"version":"3.50.1"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["FT230100468"],"award-info":[{"award-number":["FT230100468"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015624","name":"University of Jeddah","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015624","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001794","name":"University of Queensland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2028090"],"award-info":[{"award-number":["2028090"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.bioorg.2025.108248","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T12:29:28Z","timestamp":1738844968000},"page":"108248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Influence of component structural arrangement on cholesterol-antigen conjugate immunogenicity and antisera bactericidal activity against group A Streptococcus"],"prefix":"10.1016","volume":"157","author":[{"given":"Mariusz","family":"Skwarczynski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nedaa","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ummey J.","family":"Nahar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed O.","family":"Shalash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armira","family":"Azuar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashamsa","family":"Koirala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shefali J.","family":"Khisty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirmal","family":"Marasini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waleed M.","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeinab G.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istvan","family":"Toth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bioorg.2025.108248_b0005","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1039\/C5SC03892H","article-title":"Peptide-based synthetic vaccines","volume":"7","author":"Skwarczynski","year":"2016","journal-title":"Chem. Sci."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108248_b0010","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1021\/acs.chemrev.9b00472","article-title":"Peptide-based vaccines: Current progress and future challenges","volume":"120","author":"Malonis","year":"2020","journal-title":"Chem. Rev."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108248_b0015","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nrd2224","article-title":"More than one reason to rethink the use of peptides in vaccine design","volume":"6","author":"Purcell","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2025.108248_b0020","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-0716-1892-9_8","article-title":"Developments in Vaccine Adjuvants","author":"Firdaus","year":"2022","journal-title":"Methods Mol. Biol."},{"issue":"24","key":"10.1016\/j.bioorg.2025.108248_b0025","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1016\/j.vaccine.2019.04.055","article-title":"Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity","volume":"37","author":"Shi","year":"2019","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.bioorg.2025.108248_b0030","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1080\/21645515.2016.1219003","article-title":"Vaccine adjuvants: Why and how","volume":"12","author":"Christensen","year":"2016","journal-title":"Hum. Vaccin. Immunother."},{"issue":"17","key":"10.1016\/j.bioorg.2025.108248_b0035","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.2174\/0929867325666181026100849","article-title":"Lipids as Activators of Innate Immunity in Peptide Vaccine Delivery","volume":"27","author":"Bartlett","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108248_b0040","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2018.08.020","article-title":"Cationic lipids as one-component vaccine adjuvants: A promising alternative to alum","volume":"287","author":"Pizzuto","year":"2018","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.bioorg.2025.108248_b0045","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1021\/acs.molpharmaceut.1c00447","article-title":"Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines","volume":"18","author":"Chatzikleanthous","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioorg.2025.108248_b0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jcis.2024.02.134","article-title":"Cholesterol as an inbuilt immunoadjuvant for a lipopeptide vaccine against group A Streptococcus infection","volume":"663","author":"Alharbi","year":"2024","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.bioorg.2025.108248_b0055","first-page":"1","article-title":"Pathogenesis, epidemiology and control of Group A Streptococcus infection","author":"Brouwer","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108248_b0060","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41541-023-00659-1","article-title":"Global economic burden per episode for multiple diseases caused by group A Streptococcus","volume":"8","author":"Lee","year":"2023","journal-title":"npj Vaccines"},{"key":"10.1016\/j.bioorg.2025.108248_b0065","unstructured":"A.S. Sanyahumbi, S. Colquhoun, R. Wyber, J.R. Carapetis, Global disease burden of group A Streptococcus, Streptococcus pyogenes: basic biology to clinical manifestations [Internet], University of Oklahoma Health Sciences Center2016."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108248_b0070","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/s41467-023-36717-4","article-title":"Detection of Streptococcus pyogenes M1(UK) in Australia and characterization of the mutation driving enhanced expression of superantigen SpeA","volume":"14","author":"Davies","year":"2023","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108248_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12072739","article-title":"Group A Streptococcus Is Still at Large","volume":"12","author":"Lu","year":"2023","journal-title":"J. Clin. Med."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108248_b0080","doi-asserted-by":"crossref","first-page":"265","DOI":"10.15585\/mmwr.mm7210a4","article-title":"Notes from the Field: Increase in Pediatric Invasive Group A Streptococcus Infections - Colorado and Minnesota, October-December 2022","volume":"72","author":"Barnes","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108248_b0085","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S1473-3099(23)00043-9","article-title":"Surge of invasive Group A streptococcus disease","volume":"23","author":"Bagcchi","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bioorg.2025.108248_b0090","doi-asserted-by":"crossref","unstructured":"A. Azuar, W. Jin, S. Mukaida, W. Hussein, I. Toth, M. Skwarczynski, Recent advances in the development of peptide vaccines and their delivery systems against Group A Streptococcus, Vaccines 7(3) (2019) 10.3390\/vaccines7030058.","DOI":"10.3390\/vaccines7030058"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108248_b0095","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41541-023-00730-x","article-title":"Update on the development of Group A Streptococcus vaccines","volume":"8","author":"Ajay Castro","year":"2023","journal-title":"NPJ Vaccines"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108248_b0100","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41541-023-00609-x","article-title":"The Streptococcus pyogenes vaccine landscape","volume":"8","author":"Walkinshaw","year":"2023","journal-title":"NPJ Vaccines"},{"issue":"16","key":"10.1016\/j.bioorg.2025.108248_b0105","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/S0264-410X(97)00178-3","article-title":"Human antibodies to the conserved region of the M protein: opsonization of heterologous strains of group A streptococci","volume":"15","author":"Brandt","year":"1997","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108248_b0110","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2567.1996.d01-754.x","article-title":"Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci","volume":"89","author":"Brandt","year":"1996","journal-title":"Immunology"},{"issue":"8923","key":"10.1016\/j.bioorg.2025.108248_b0115","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0140-6736(94)92083-4","article-title":"Toward a vaccine for rheumatic-fever-identification of a conserved target epitope on M-protein of group A streptococci","volume":"344","author":"Pruksakorn","year":"1994","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108248_b0120","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41541-024-00863-7","article-title":"challenges, opportunities, vaccine-based solutions, and economics","volume":"9","author":"Bloom","year":"2024","journal-title":"NPJ Vaccines"},{"issue":"10","key":"10.1016\/j.bioorg.2025.108248_b0125","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1086\/374800","article-title":"Protection against group A streptococcus by immunization with J8-diphtheria toxoid: Contribution of J8-and diphtheria toxoid-specific antibodies to protection","volume":"187","author":"Batzloff","year":"2003","journal-title":"J. Infect Dis."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108248_b0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198658","article-title":"Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial","volume":"13","author":"Sekuloski","year":"2018","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.bioorg.2025.108248_b0135","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1016\/j.bmc.2016.03.063","article-title":"Structure-activity relationship of lipid core peptide-based Group A Streptococcus vaccine candidates","volume":"24","author":"Chan","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108248_b0140","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1021\/acsmedchemlett.9b00239","article-title":"Cholic Acid-based Delivery System for Vaccine Candidates against Group A Streptococcus","volume":"10","author":"Azuar","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"issue":"41","key":"10.1016\/j.bioorg.2025.108248_b0145","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.1016\/j.vaccine.2007.07.047","article-title":"Totally synthetic peptide-based immunocontraceptive vaccines show activity in dogs of different breeds","volume":"25","author":"Walker","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108248_b0150","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1046\/j.0019-2805.2001.01271.x","article-title":"Identification of canine helper T-cell epitopes from the fusion protein of canine distemper virus","volume":"104","author":"Ghosh","year":"2001","journal-title":"Immunology"},{"key":"10.1016\/j.bioorg.2025.108248_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2022.108029","article-title":"The influence of component structural arrangement on peptide vaccine immunogenicity","volume":"60","author":"Alharbi","year":"2022","journal-title":"Biotechnol. Adv."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108248_b0160","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1208\/s12248-014-9707-3","article-title":"Peptide amphiphile micelles self-adjuvant group A streptococcal vaccination","volume":"17","author":"Trent","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.bioorg.2025.108248_b0165","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejmech.2019.06.047","article-title":"Structure-activity relationship of group A streptococcus lipopeptide vaccine candidates in trimethyl chitosan-based self-adjuvanting delivery system","volume":"179","author":"Nevagi","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108248_b0170","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.actbio.2016.04.012","article-title":"Liposome-based intranasal delivery of lipopeptide vaccine candidates against group A streptococcus","volume":"41","author":"Ghaffar","year":"2016","journal-title":"Acta Biomater."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108248_b0175","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.4049\/jimmunol.169.9.4905","article-title":"Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines","volume":"169","author":"Zeng","year":"2002","journal-title":"J. Immunol."},{"issue":"39","key":"10.1016\/j.bioorg.2025.108248_b0180","doi-asserted-by":"crossref","first-page":"9892","DOI":"10.1002\/chem.201801378","article-title":"Influence of physicochemical properties of lipopeptide adjuvants on the immune response: A rationale for engineering a potent vaccine","volume":"24","author":"Eskandari","year":"2018","journal-title":"Chem-Eur J"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108248_b0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011216","article-title":"Linear and Branched Glyco-Lipopeptide Vaccines Follow Distinct Cross-Presentation Pathways and Generate Different Magnitudes of Antitumor Immunity","volume":"5","author":"Renaudet","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2025.108248_b0190","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax2285","article-title":"Poly(amino acids) as a potent self-adjuvanting delivery system for peptide-based nanovaccines","author":"Skwarczynski","year":"2020","journal-title":"Sci Adv 6"},{"key":"10.1016\/j.bioorg.2025.108248_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.06.027","article-title":"Self-assembled monovalent lipidated mannose ligand as a standalone nanoadjuvant","author":"Nahar","year":"2024","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.bioorg.2025.108248_b0200","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202001264","article-title":"Self-Assembling Glycopeptide Conjugate as a Versatile Platform for Mimicking Complex Polysaccharides","volume":"7","author":"Wang","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bioorg.2025.108248_b0205","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.eurpolymj.2017.02.014","article-title":"The application of self-assembled nanostructures in peptide-based subunit vaccine development","volume":"93","author":"Zhao","year":"2017","journal-title":"Eur. Polym. J."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108248_b0210","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.0818-9641.2004.01271.x","article-title":"Vaccines that facilitate antigen entry into dendritic cells","volume":"82","author":"Gamvrellis","year":"2004","journal-title":"Immunol. Cell Biol."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108248_b0215","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jconrel.2005.02.027","article-title":"Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles","volume":"105","author":"Kwon","year":"2005","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108248_b0220","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/smll.200901158","article-title":"Effect of Surface Properties on Nanoparticle\u2013Cell Interactions","volume":"6","author":"Verma","year":"2010","journal-title":"Small"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108248_b0225","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1021\/acs.jmedchem.0c01660","article-title":"Poly(hydrophobic amino acid)-Based Self-Adjuvanting Nanoparticles for Group A Streptococcus Vaccine Delivery","volume":"64","author":"Azuar","year":"2021","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108248_b0230","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/cmdc.201500036","article-title":"Investigation of Structure\u2013Activity Relationships of Synthetic Anti\u2010Gonadotropin Releasing Hormone Vaccine Candidates","volume":"10","author":"Chang","year":"2015","journal-title":"ChemMedChem"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108248_b0235","article-title":"Chemical Conjugation Strategies for the Development of Protein-Based Subunit Nanovaccines","volume":"9","author":"Lu","year":"2021","journal-title":"Vaccines (basel)"},{"key":"10.1016\/j.bioorg.2025.108248_b0240","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3389\/fchem.2020.00284","article-title":"Carbohydrate Conjugates in Vaccine Developments","volume":"8","author":"Lang","year":"2020","journal-title":"Fron Chem"},{"issue":"8","key":"10.1016\/j.bioorg.2025.108248_b0245","doi-asserted-by":"crossref","first-page":"6822","DOI":"10.1021\/acs.jmedchem.4c00412","article-title":"Multifunctional Lipidated Protein Carrier with a Built-In Adjuvant as a Universal Vaccine Platform Potently Elevates Immunogenicity of Weak Antigens","volume":"67","author":"Zhou","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108248_b0250","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jconrel.2023.01.062","article-title":"Novel sialoglycan linkage for constructing adjuvant-protein conjugate as potent vaccine for COVID-19","volume":"355","author":"Wen","year":"2023","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108248_b0255","doi-asserted-by":"crossref","first-page":"235","DOI":"10.7774\/cevr.2022.11.3.235","article-title":"Development of mucosal vaccine delivery: an overview on the mucosal vaccines and their adjuvants","volume":"11","author":"Anggraeni","year":"2022","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.bioorg.2025.108248_b0260","article-title":"Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines","volume":"118731","author":"Zheng","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108248_b0265","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","article-title":"Mucosal vaccines \u2014 fortifying the frontiers","volume":"22","author":"Lavelle","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108248_b0270","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4155\/tde-2016-0068","article-title":"Intranasal delivery of nanoparticle-based vaccines","volume":"8","author":"Marasini","year":"2017","journal-title":"Ther. Deliv."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108248_b0275","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/17425247.2020.1731468","article-title":"Non-invasive mucosal vaccine delivery: advantages, challenges and the future","volume":"17","author":"Skwarczynski","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108248_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e24662","article-title":"Research progress on emulsion vaccine adjuvants","volume":"10","author":"Huang","year":"2024","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108248_b0285","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3390\/vaccines11020305","article-title":"The Development of Surface-Modified Liposomes as an Intranasal Delivery System for Group A Streptococcus Vaccines","volume":"11","author":"Yang","year":"2023","journal-title":"Vaccines"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108248_b0290","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2174\/1567201813666160721141322","article-title":"Highly Immunogenic Trimethyl Chitosan-based Delivery System for Intranasal Lipopeptide Vaccines against Group A Streptococcus","volume":"14","author":"Marasini","year":"2017","journal-title":"Curr. Drug Deliv."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108248_b0295","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/infdis\/jiz528","article-title":"Lipopeptide-Based Oral Vaccine Against Hookworm Infection","volume":"221","author":"Bartlett","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bioorg.2025.108248_b0300","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/1573406412666160720093138","article-title":"The Role of Size in Development of Mucosal Liposome-Lipopeptide Vaccine Candidates against Group A Streptococcus","volume":"13","author":"Ghaffar","year":"2017","journal-title":"Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108248_b0305","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1021\/acs.jpcb.2c07256","article-title":"QCM-D Investigations on Cholesterol-DNA Tethering of Liposomes to Microbubbles for Therapy","volume":"127","author":"Armistead","year":"2023","journal-title":"J. Phys. Chem. B"},{"issue":"29","key":"10.1016\/j.bioorg.2025.108248_b0310","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1016\/j.biomaterials.2007.06.008","article-title":"Cholesterol transport from liposomal delivery vehicles","volume":"28","author":"Kheirolomoom","year":"2007","journal-title":"Biomaterials"},{"issue":"980","key":"10.1016\/j.bioorg.2025.108248_b0315","article-title":"Optimization of the Linker Length of Mannose-Cholesterol Conjugates for Enhanced mRNA Delivery to Dendritic Cells by Liposomes","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108248_b0320","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.3390\/molecules22101598","article-title":"Glycyrrhetinic Acid Liposomes Containing Mannose-Diester Lauric Diacid-Cholesterol Conjugate Synthesized by Lipase-Catalytic Acylation for Liver-Specific Delivery","volume":"22","author":"Chen","year":"2017","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.bioorg.2025.108248_b0325","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid Nanoparticles\u2500From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108248_b0330","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1021\/acsinfecdis.0c00722","article-title":"Immunogenicity Assessment of Cell Wall Carbohydrates of Group A Streptococcus via Self-Adjuvanted Glyco-lipopeptides","volume":"7","author":"Khatun","year":"2021","journal-title":"ACS Infect. Dis."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108248_b0335","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1021\/acs.jmedchem.0c00203","article-title":"Structure\u2013Activity Analysis of Cyclic Multicomponent Lipopeptide Self-Adjuvanting Vaccine Candidates Presenting Group A Streptococcus Antigens","volume":"63","author":"Madge","year":"2020","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108248_b0340","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1021\/acsinfecdis.0c00452","article-title":"Polyethylenimine: An Intranasal Adjuvant for Liposomal Peptide-Based Subunit Vaccine against Group A Streptococcus","volume":"6","author":"Dai","year":"2020","journal-title":"ACS Infect. Dis."},{"issue":"16","key":"10.1016\/j.bioorg.2025.108248_b0345","doi-asserted-by":"crossref","first-page":"13966","DOI":"10.1074\/jbc.M110.186338","article-title":"Sequence-independent control of peptide conformation in liposomal vaccines for targeting protein misfolding diseases","volume":"286","author":"Hickman","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108248_b0350","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1034\/j.1399-3011.2002.21018.x","article-title":"The kinetics of the removal of the N-methyltrityl (Mtt) group during the synthesis of branched peptides","volume":"60","author":"Li","year":"2002","journal-title":"J. Pept. Res."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108248_b0355","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.3390\/pharmaceutics14102151","article-title":"Development of Multilayer Nanoparticles for the Delivery of Peptide-Based Subunit Vaccine against Group A Streptococcus","volume":"14","author":"Kiong","year":"2022","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.bioorg.2025.108248_b0360","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1021\/acsinfecdis.3c00159","article-title":"Activity Relationship of Poly(ethylenimine)-Based Liposomes as Group A Streptococcus Vaccine Delivery Systems","volume":"9","author":"Jin","year":"2023","journal-title":"ACS Infect. Dis."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825001282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825001282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T21:31:01Z","timestamp":1763847061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825001282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":72,"alternative-id":["S0045206825001282"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108248","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of component structural arrangement on cholesterol-antigen conjugate immunogenicity and antisera bactericidal activity against group A Streptococcus","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108248","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108248"}}